| General Information | |||
|---|---|---|---|
| Term | glycogen storage disease VII | ID (Ontology) | DOID:11721 (Human Disease) |
| Definition | A glycogen storage disease that is characterized by exercise intolerance, muscle cramping, exertional myopathy, and compensated hemolysis and that has_material_basis_in homozygous or compound heterozygous mutation in the PFKM gene, which encodes muscle phosphofructokinase, on chromosome 12q13. | ||
| Also Known As | "Glycogen storage disease 7" ; "glycogen storage disease type VII" ; "Glycogen storage disease, type VII" (for all, see Synonyms field below) | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
glycogen metabolism disorder |__glycogen storage disease_____ autosomal genetic disease | |__autosomal recessive disease__| glycogen storage disease VII 1 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a |
autosomal recessive disease glycogen storage disease |
||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
ICD10CM:E74.09 MESH:D006014 MIM:232800 NCI:C118437 SNOMEDCT_US_2023_03_01:89597008 UMLS_CUI:C0017926 |
|||